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The application of rare earth complexes in several techniques and technologies requires their
strong, i.e. preferably covalent, fixation to a substrate. The particularly useful luminescence
properties of – readily available – rare earth b-diketonate complexes can widely be maintained
on co-ligation with an epoxi-functionalised 1,10-phenanthroline. The linkage of epoxidised
1,10-phenanthroline to common peptides and proteins proceeds to free –SH and –NH2 groups,
with a clear preference for –SH. Subsequent luminescence activation with Eu(ttfa)3 yields strongly
emissive species, in which the Eu(ttfa)3 coordinates to the N-bidentate phenanthroline protruding
from the peptide. Luminescence, FTIR, ESI-MS, NMR and life time measurements provide the
evidence for successful anchoring of the marker to the peptides. Additionally, the optical
properties have been evaluated against analogous Eu complexes in polymer matrices and solution.
The procedure described holds the promise of a facile method for the detection of free –SH
groups in biological entities and their discrimination from oxidised –S–S– bridges.
Introduction
The outstanding luminescent properties of rare earth complexes
such as aromatic carboxylates and diketonates were recognised
several decades ago. Next to persisting fundamental interest,
they have received renewed attention more recently in various
emerging fields of applications, such as e.g. (molecular) organic
light emitting diodes,1 sensors,2 or bioassays.3 Particular impact
is owed to the event of the commercialization of the DELFIA
system,4 in which the long life emission decay time of many of
such complexes is exploited to discriminate the characteristic
rare earth emissions against inherent matrix emissions of
biological matter. Thus, protein emission signals for example,
fading on the nanosecond time scale, can almost completely be
ignored, if the rare earth emission is monitored with a time
delay of up to several hundred microseconds. Additional factors
synergistically contribute to the usability of the rare earths in
these applications, among them the narrow emission lines and
the large (apparent) Stoke shifts as well as the quantum yields,
which can amount to near unity.
Bidentate b-diketonates constitute one class of thoroughly
investigated ligands, which led to a well founded understanding
of the underlying excitation, energy transfer and emission mechan-
isms, as summarised and shown in corresponding reviews.5 In brief,
the efficient luminescence of the complexes is facilitated by allowed,
thus strong singlet 1S0-
1S* absorptions, followed by spin–orbit
coupling supported, intra-ligand energy transfer to a ligand triplet
state 3T, from which the energy is transferred to the attached rare
earth ion and eventually emitted from the characteristic, well known
rare earth excited states, e.g. 5D0 in Eu
3+ or 5D4 in Tb
3+. Early
investigations of rare earth diketonates already revealed the advan-
tageous effect of co-coordination,6 which essentially removes
coordinated water from the luminescent center. If the co-ligands
exhibit suitable absorptions, theymay additionally contribute to the
overall optical properties; popular examples are aromatic chelators
such as 1,10-phenanthroline or 2,20-bipyridine. The eight-coordi-
nate molecular complexes thus typically obtained are soluble in
non-polar solvents ormay even be evaporated intact. As convenient
as this might seem in some instances, for many conceivable
applications, it may be necessary however, to link these complexes
to a matrix, be it of inorganic, organic, polymeric or biological
nature. Thus, we are searching for complexes with versatile,
reactive functional groups, readily allowing a covalent affix-
ment to abovementioned matrices.
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The present report is devoted to the use of the well known
tris(2-thenyl-4,4,4-trifluorbutane-1,3-dionato)Eu (‘‘Eu(ttfa)3’’),
and 5,6-epoxy-5,6-dihydro-1,10-phenanthroline (‘‘epoxi-
phen’’),7 as a functional co-ligand. Its capability to bond
and label the biologically relevant peptides glutathione
(‘‘GluSH’’), triglycine (‘‘Trigly’’), and melanostatine (‘‘Mel’’)
is elucidated (see Fig. 1). Next to their presumed model
character for the more cumbersome and complex reactions
with proteins, GluSH, exhibiting free –SH groups, was chosen
for its vital role as an antioxidant, and its indicator function
for cellular toxicity,8 Trigly for the absence of –SH groups,
and Mel, a melanin inhibitor, for its amide function and its
exclusively secondary amine groups.9
Results and discussion
Reactions of epoxiphen (5,6-epoxy-5,6-dihydro-1,10-
phenanthroline) with peptides
The expected reaction of epoxiphen with polar groups like amino
and thiol, respectively, would generally proceed according to
eqn (1a) or eqn (1b).10,11
The progress of the reaction can readily be followed by
observing the disappearance of the asymmetric stretch of the
epoxy C–O–C vibration in the infrared spectra (IR, 882 cm1,
see Fig. S1b, ESIw). To confirm this assignment, a model
reaction was carried out with glutathione and butylamine at
pH = 4, the product of which was practically void of COC
vibrations in the spectral range of interest (Fig. S1g, ESIw).
The amine coupled reaction products 1a can in fact be
identified for Trigly and Mel. However, a relatively high pH
of 10 was required, while at a pH of 4, no reaction could be
observed at all. At intermediate pH values the reactions rates
are drastically reduced, such that unreacted epoxiphen could
still be detected even after a reaction period of 3 days.
As opposed to that, the thiole linkage appears to be preferred,
as was demonstrated using GluSH, where the epoxiphen has
completely vanished after 50 hours even at a pH as low as 4.
The corresponding UV absorption spectra for the reactions
of GluSH at pH 4 and 10 are reproduced in Fig. 2 along with
the starting materials. At pH values of 49 the disappearance
of the H–S– valence mode (2526 cm1) in the IR spectrum
serves as an additional monitor for detection, furthermore, a
slight shift of epoxiphen bands is observed (Fig. S1e, ESIw),
while products related to eqn (1a) (amine linkage) are not. Next
to mentioned epoxy C–O–C vibrations, the solid epoxiphen
ligand itself can be excited in the UV (250–400 nm) to exhibit a
detectable emission in the blue to green spectral region, the
exact location of which appears to be depending on the ligand’s
substituents, i.e. –NH–R or –S–R (see Fig. S4 also, ESIw).
Qualitatively, the ligand emission spectra are blueshifted with
increasing electron richness. Accordingly, the emission of the
thiol coupled di-anion (the di-sodium salt, ‘‘Na2GluS-phen’’) is
also blueshifted by approximately 50 nm, and, additionally, its
emission intensity is enhanced considerably in the di-sodium
salt over the free acid (Fig. 2).
Further evidence for the formation of the thiol-linked
epoxiphen (eqn (1b), Scheme 1) can be derived from the
corresponding MS and NMR spectra. In the ESI-MS in
particular, significant fragmentation reactions are water releases
and a characteristic cleavage of the fragment H2NCH(CH2S-
phen)CONHCH2COOH (m/z = 357 Da) (see Fig. S2, ESIw
for further details). Because of the high ionization efficiency of
the phen-group, several corresponding fragment ions appear,
indicating the sulfur linkage. In contrast, bonds to oxygen or
nitrogen would generate two other pairs of characteristic
fragment ions each (215 and 197 or 214 and 196, respectively).
Compared with this, MS spectra obtained for the amine based
reaction of epoxiphen with Mel and Trigly indicate the
presence of the amine linkage (Scheme 1, eqn (1a)), however, the
Mel and Trigly materials were obviously strongly contaminated
with unidentified by-products and starting materials, respectively,
and were not pursued further (for completion, their absorption
and emission spectra are depicted in Fig. S4, ESIw). Finally, the
NMR spectra agree with Fig. 1b for the glutathione substitution
also (see Experimental section). In addition the 13C NMR data
suggest the presence of two conformers in solution.
Fig. 1 Structure of analytes: (a) glutathione (‘‘GluSH’’), (b) melanostatine
(‘‘Mel’’), (c) triglycine (‘‘Trigly’’).
Fig. 2 Left: absorption spectra (5  105 mol l1) of (a) epoxiphen,
solids of (b) GluSH, (c) H2GluS-phen (pH = 4), (d) Na2GluS-phen
(pH= 10). Right: emission spectra of (e) epoxiphen, (f) H2GluS-phen,
(g) Na2GluS-phen.
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The complex Eu(ttfa)3epoxiphen
While the preparation of epoxiphen, its conversion into amino-
phenanthroline and the successive complexation with Eu3+ to
yield Eu(ttfa)3aminophen
13,14 has been reported, the complex
Eu(ttfa)3epoxiphen (Fig. 3) and its spectral features have to the
best of our knowledge not been described before. This is some-
what surprising, because the epoxiphen co-ligand itself is easily
accessible7 (or even available commercially), grants a ready
straightforward access to Eu(ttfa)3epoxiphen, which is in turn
a very interesting complex due to the reactive epoxigroup. The
co-ligand thus provides an elegant coupling substituent for
numerous applications, in which covalent linkage to substrates
is mandatory such as in sensors, markers, etc.
Eu(ttfa)3epoxiphen proved to retain its spectral features and
efficiency in comparison to the ‘original’ parent complex
Eu(ttfa)3phen (quantum yields Y of 66% compared to 82%
and corresponding lifetimes of 864 ms and 945 ms, respectively,
we should mention here that other data reported for Eu(ttfa)3phen
amount to 69% and 976 ms, respectively,15 and 82%,16 see
Table 1).
Functionalization of the epoxiphen coupled glutathione
(GluS-phen) with Eu(ttfa)3
The final functionalization of the epoxiphen-modified glutathione
with Eu(ttfa)3 readily proceeds in a water–ethanol solution within
a few hours (Scheme 2). Again, despite some band broadening, IR
is a good tool for monitoring characteristic changes of the starting
materials in the reaction.
IR absorptions of Eu(ttfa)3 and epoxiphen at 1580, 1560,
1433, 1216, 1013 cm1 are shifted to higher frequencies on
co-complexation according to Fig. S1 (ESIw). The very same
effects are also observed on co-complexation of GluS-phen
to the europium diketonate. While on co-coordination of
epoxiphen the characteristic 751 cm1 absorption band (out-
of-plane bending modes of the hydrogen atoms) is red shifted
and split into a doublet at approximately 744 and 721 cm1, in
GluSH-phen the corresponding 749 cm1 band appears as a
doublet at 746 and 720 cm1 on coordination to Eu(ttfa)3.
These findings are in complete agreement with the spectra
reported for the co-coordination of 1,10-phenanthroline in
similar complexes, e.g. Eu(O2C–CHQCH–C6H5)3phen
17 or
Eu(NO3)3(phen)2.
18 Additionally, we observe redshifts of
the phen absorptions at 800 cm1 and 707 cm1 to 786 cm1
and 682 cm1 on Eu-coordination and from 709 cm1 to
682 cm1, respectively, in the corresponding Eu(ttfa)3(GluS-
phen). The coordination of epoxiphen or GluS-phen also
gives rise to a slight redshift from 1544 to 1539 cm1 of
the perturbed diketonate carbonyl groups of the ttfa ligand
(Fig. S1, ESIw).
Ultimately, spectroscopic evidence for the presence of the
linkage between the Eu(ttfa)3 and the modified glutathione is
provided by the spectral and lifetime analysis of the Eu emissions
lines. The Eu3+ emission is known to be particularly sensitive to the
chemical environment in that the presence of water or other entities
exhibiting high vibrational frequencies in the first coordination
sphere, inevitably lead to radiationless decays, i.e. reduced lifetimes
of the excited states and reduced efficiencies.
Typically, 1,10-phenanthroline and other bidentate co-ligands
to the diketonates provide very good screening and thus
Fig. 3 Sketch of Eu(ttfa)3epoxiphen. Structural details of the parent
Eu(ttfa)3phen may be found in ref. 12.
Table 1 Luminescence properties of Eu(ttfa)3epoxiphen and GluSH-
coupled complexes: excitation and emission maxima (lexc, lem), lumines-






(nm) t (ms) Y (%)
Eu(ttfa)3epoxiphen 360 612 864 2 66
a
Eu(ttfa)3phen 380 612 945 11 82
a,b, 69c
Eu(ttfa)3(H2O)2 375 610 198 1 23
c
Eu(ttfa)3GluSH 340 612 266 1
a —
Eu(ttfa)3GluS-phen 360 612 t1: 162 11 (8%) 20.6
t2: 494 8 (92%)
Eu(ttfa)3bu-aminophen
d 360 612 585 1a —
Eu(ttfa)3aminophenMR
e 349 612 500 22 5f
Eu(ttfa)3phen/PMMA 360 612 552 2 (spheres) 35
a
Eu(ttfa)3/PMMA 350 615 59 1 (20%) 0.6
a
362 3 (80%)
Eu(ttfa)3phen/silicone 365 612 526 1 8
Eu(ttfa)3phen/PUR 365 615 601 1 36.7
a
Eu(ttfa)3/PUR 380 614 558 1 17.6
a This work. b Ref. 16. c Ref. 15. d From reaction of epoxiphen with
butyl amine prior to complexation. e MR=Merrifield resin. f Ref. 13.
PUR = polyurethane (from hexamethylenediisocyanate and polyol),21
PMMA = polymethylmetacrylate.
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enable high efficiencies, often in excess of 80%, which are
accompanied by decay times up to the millisecond regime.
A comparison of the emission spectra of Eu(ttfa)3phen,
Eu(ttfa)3epoxihen and Eu(ttfa)3(GluS-phen) is enabled in
Fig. 4. The emission pattern of Eu(ttfa)3(GluS-phen) resembles
that of Eu(ttfa)3phen; the line broadening is analogous to that
observed for attachment to the Merrifield resin. Thus the
luminescence spectra support the assumption of structural
analogy in the immediate Eu3+ coordination sphere. Further,
Table 1 allows a quantitative comparison of the optical proper-
ties of the present Eu(ttfa)3epoxiphen and Eu(ttfa)3(GluS-phen)
with the parent compounds Eu(ttfa)3 and Eu(ttfa)3phen as the
pure compound and some matrix embedded materials.19,20
The increase of the radiative lifetimes of the Eu3+ ions on
co-coordinating GluS-phen to Eu(ttfa)3 and the measured
quantum yields are in good agreement with results found for
mentioned phen-functionalised Merrifield resin (polystyrene)13
and generally in line with the decay depreciation brought about
by secondary interactions of the complexes with ‘‘high
frequency matrices’’ (–C–H vibrations of polymer matrices
or other species, see Table 1). The GluS-phen ligand further-
more introduces a second lifetime component, albeit of
weak amplitude (8%) only, the assignment of which is not
unambiguous at present. We speculate that a partial substitution
of ttfa by a GluS-phen carboxylate group due to the higher
basicity of the ttfa ligand may have taken place, a behaviour
that we have previously observed at pH o 7 with other
carboxylic acids. The formation of trace amounts of a
Schiff-base from the GluS-phen aminofunctions and ttfa,
analogous to b-diketonates of Cu2+ and VO2+,22,23 should
also not be ruled out.
Summary and conclusions
Well known diketonato complexes of Eu3+ can readily be
co-coordinated with the bidentate co-ligand 5,6-epoxy-5,6-
dihydro-1,10-phenanthroline. The resulting luminescent complexes
are thus enabled to undergo covalent coupling reactions with a
multitude of conceivable reaction partners. However, in a
series of reactions with amines and thiols we found a marked
preference for coupling via –SH groups. It proved to be
advantageous, to react the co-ligand with the epoxiphen prior
to the eventual luminescence activation with the Eu diketonate
complex Eu(ttfa)3. Consequently, the reaction of epoxiphenan-
throline with e.g. glutathione at moderate pH values exclusively
leads to a sulfur linkage to the phenanthroline. The modified
glutathione obtained can readily be functionalised optically
with europium diketonates, such as Eu(ttfa)3, and thus be
rendered luminescent. The scheme described holds the promise
of becoming a sensitive optical sensor for glutathione, but
possibly other biologically relevant molecules as well. As an
example, the reduced form of BSA may be mentioned here, to
which we were able to couple the complex as well. The epoxy
complexes and the gluthathione derivatives were compared to
known standard europium luminophores and found to be in a
very promising efficiency regime optically. In future work, we
will try to optimise the synthesis and investigate the detection
limits for glutathione in particular. However, due to its capability
of covalent binding, the complex is also of interest for the facile
synthesis of inorganic–organic hybrid materials, i.e. for backbone
anchored luminescent complexes within polymers, which will be
a second focus in coming research.
Experimental section
General experimental methods
IR spectra were recorded on Perkin Elmer Spectrum One FTIR
spectrometer as KBr disks in the range between 4000 cm1 and
450 cm1. A discussion of the relevant spectral features is
conducted in the text. Given the multitude of absorption bands,
a listing shall here be refrained from; instead, spectra are
reproduced along with a comparison of relevant analogs in
Fig. S1 (ESIw).
Mass spectroscopic experiments were carried out on an
Agilent 1100 series binary HPLC system (Agilent Technologies,
Waldbronn, Germany) coupled with a 4000QTRAPTM linear
ion trap mass spectrometer (Applied Biosystem/MDS SCIEX,
Foster City, CA, USA) equipped with a TurboIon spray source.
Separation was achieved on a ProntoSIL 120-C18-SH (Bischoff
Chromatography, Leonberg, Germany) column (150  2 mm
i.d., 3 mm particle size) kept at 20 1C during analysis. Gradient
elution was done with deionised water with 0.1% formic acid
Fig. 4 Reflectance and normalised excitation and emission spectra of
(a) Eu(ttfa)3phen (lexc = 380 nm), (b) Eu(ttfa)3(GluS-phen) (lexc =
360 nm) and (c) Eu(ttfa)3epoxiphen (lexc = 360 nm). Emission
monitored at 612 nm. The non-normalized emission intensity in
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(solvent A) and acetonitrile with 0.1% formic acid (solvent B)
at a constant flow rate of 300 ml min1. The gradient profile
was 1% B for 5 min isocratic, from 5 to 25 min a linear
increase from 1% B to 99% B, an isocratic step for 10 min and
a return to 1% B at 26 min and 10 min isocratic for
re-equilibration. The injection volume was 15 ml. The MS
was operated in the positive Enhanced MS (EMS) mode ion
scanning from 100–700 nm. The parameters used for all
methods were optimised performing a Flow Injection Analysis
(FIA) with standards and led to the following settings for all
analyses: curtain gas (N2) 10 arbitrary units (au), temperature
of the source 400 1C, nebuliser gas (N2) 50 au and heater
gas (N2) 20 au. For compound identification MS/MS and
MS/MS/MS experiments were performed in Enhanced Product
Ion (EPI) Scan mode. Collision Energy (CE) was optimised
individually for each precursor ion.
1H and 13C NMR spectra of Na2GluS-phen were measured
on an AVANCE I (Bruker) 400.13 MHz NMR spectrometer
equipped with a BBO(F) sample head with a z-gradient.
The sample was dissolved in D2O at a concentration of
0.187 mol l1, 3-(trimetylsilyl)propane sulfonic acid sodium
salt (TSPSA) was used as an internal standard (chemical shift
0.015 ppm). 13C spectra are CH-decoupled.
UV-Vis absorption spectra were obtained using an Ocean
Optics HR4000 fibre spectrometer with a 5 mm slit and a 20 W
deuterium/halogen light source. Emission and excitation
spectra of the powderous products were measured at room
temperature on an ARC spectrometer (monochromators of
300 mm focal length, a 450 W Xe lamp as a light source,
photomultiplier tube P2) equipped with optical fibres. The
quantum yields were obtained by measuring relative to a
Lumogen Red F300 doped (50 ppm) PMMA powder standard,
for which a quantum yield of 42% was assumed.
Luminescence decay times were measured using an Edinburgh
Instruments FL 920 lifetime spectrometer (single photon counting)
equipped with an Edinburgh Instruments mF900 flash lamp and a
Hamamatsu extended red sensitivity photomultiplier tube.
Synthesis
5,6-Epoxy-5,6-dihydro-1,10-phenanthroline (epoxiphen). Epoxi-
phen was synthesised according to Shen and Sullivan7 with the
exception that the formation of epoxiphen was monitored via IR
spectroscopy. The spectra were identical to a commercial product
purchased from Aldrich.
Coupling of GluSH with (epoxiphen). 200 mg GluSH
(0.651 mmol, Aldrich) were dissolved in 10 ml dest. water
and mixed with 120 mg 5,6-epoxy-5,6-dihydro-1,10-phenan-
throline (0.612 mmol), dissolved in 2 ml methanol. The
mixture was stirred at room temperature for at least 20 h.
The solvent was evaporated under vacuum (103 mbar) at room
temperature. The yellow powderous product was washed several
times with toluene. The toluene contained no residue after
evaporation, if the reaction time exceeded 40 h.
In ESI-MS, the signal of highest mass at 405 Da corre-
sponds to the quasi molecular ion [M + H]+ of composition
C22H26N5O7S
+. The complete fragmentation scheme is given
in Scheme S2 (ESIw). For a discussion of relevant IR vibra-
tions see text (further spectral information in Fig. S1, ESIw).
Na2GluS-Phen. 200 mg GluSH (0.651 mmol) were dissolved
in 10 ml dest. water, the solution was adjusted with 2 M NaOH
solution to a pH of 9, and mixed with 127.4 mg 1,10-phenan-
throline-5,6-epoxide (0.65 mmol) dissolved in 2 ml methanol.
The mixture was stirred at room temperature for 20 to 45 h,
after which the solvents were evaporated under vacuum
(103 mbar) at room temperature. The slightly yellowish
powder was washed several times with toluene (at 45 h reaction
time no residue was observed after evaporation of toluene). For
the reaction at pH E 9 of GluSH with epoxiphen, the highest
signal in MS appears at m/z = 504, corresponding to [GluS-
phen + H]+ (C10H16N3O6S–HOC12H9N2) (see text, Fig. S1 and
Scheme S1, ESIw). In NMR all signals can be assigned to the
product indicated by eqn (1b), albeit in 13C, the appearance of
doublets (some only under very strong magnification) suggests the
presence of two fairly stable conformers in the solution:
1H NMR dH 1.88–1.87 (d, 2H); 2.37 (s, 2H); 2.805–2.92 (m,
1H); 3.1–3.32 (m, 1 H); 3.28 (s, 1H); 3.80 (d, 2H); 4.56 (s, 1H);
4.60 (d, 1H); 5.18 (d, 1H); 7.5–7.6 (m, 2H); 8.00 (dd, 2H); 8.70
(d, 1H); 8.75 (d, 1H). 13C NMR dH 33.24 (s); 34.91 (s); 35.20,
35.30 (d); 46.06 (s); 49.37, 49.88 (d); 55.13, 55.71 (d); 58.0 (s);
72.07, 72.35 (d); 127.95, 128.0 (d); 128.20 (s); 134.15, 134.27
(d); 134.41 (s); 141.55, 141.65 (d); 151.22, 151.23 (d); 151.45,
141.48 (d); 152.18, 152.27 (d); 153.1 (s); 174.11, 174.15 (d);
178.77, 178.8 (d); 178.9 (s); 184.22, 184.26 (d). The signals for
GluSH strongly depend on pH. The assignment summarised in
Table S1 (ESIw) follows previous assignments on GluSH.24,25
Eu(ttfa)3(epoxiphen). Eu(ttfa)3(H2O)2 was prepared accord-
ing to Charles and Ohlmann.26 The epoxiphen-cocomplex was
subsequently obtained by dissolution of 0.851 g Eu(ttfa)3-
(H2O)2 (1 mmol) in 15–20 ml ethanol. 0.196 g epoxiphen
were dissolved in 10 ml ethanol and added to the previous
solution and the mixture left overnight at room temperature
for the complex crystallization. The powder was filtered off,
washed with n-hexane and dried under vacuum at room
temperature. Analytical data for C36H30N2O3S3F9Eu: Eu
15.02%, found 15.06%; C 42.74%, found 43.10%; S 9.51%,
found 9.25%.
Eu(ttfa)3(Na2GluS-phen). 200mgNa2GluS-phen (0.364mmol)
were dissolved in 2 ml dest. water and 7 ml ethanol. 310 mg
Eu(ttfa)3 were dissolved in 1 ml ethanol and added to the
conjugated tripeptide solution. The precipitate formed was
heated for 9 h at 50 1C with an additional 7 ml of ethanol.
After cooling the precipitate was centrifuged and washed
several times with ethanol to remove non-reacted Eu(ttfa)3.
Yield 30%. Analytical data for Na2C46H35N5O13S4F9Eu:
Eu 11.15% (found 11.10%), C 40.54% (found 40.72%), S 9.38%
(found 9.40%).
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